Release Date: 30/01/17 17:25 Summary: Quarterly Activities Report & Appendix 5B - December 2016 Price Sensitive: Yes Download Document 325.71KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status